-+ 0.00%
-+ 0.00%
-+ 0.00%

*Lisata Therapeutics Enters Into Term Sheet To Be Acquired By Kuva Labs For $4.00 Per Share In An All-Cash Tender Offer >LSTA

Dow Jones·01/21/2026 12:00:00

Please log in to view news